In the current cycle, VistaGen Therapeutics Inc (VTGN) Stock is showing signs of growth

Jefferies raised the price target for the VistaGen Therapeutics Inc (NASDAQ:VTGN) stock from “a Hold” to “a Buy”. The rating was released on December 07, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report […]